Genmab — Januar 2023
-
Interessant artikel om CAR-T contra Bispecific Antibodies, Godt nytår ! https://themmrf.org/2022/12/28/answers-to-faqs-from-our-12-20-22-expert-session-on-myeloma-highlights-from-the-ash-2022-meeting/
-
Godmorgen
-
Genmab-topchef: Tre kræftmidler er på vej mod væsentlige milepæle i 2023 - https://medwatch.dk/Medicinal___Biotek/article14766808.ece - godt nytår
-
En lille nyhed, som ikke er nævnt fra før nytår. FDA godkender kræftmiddel fra Roche https://medwatch.dk/Medicinal___Biotek/article14761309.ece
-
-
Genmab to Present at the 41st Annual J.P. Morgan Healthcare Conference https://www.proinvestor.com/investornyt/922129/genmab-to-present-at-the-41st-annual-jp-morgan-healthcare-conference
-
-
-
Og så kører 1042 jo nu også i flere kombier med kemo, og har en arm med bugspytkirtlen også. https://clinicaltrials.gov/ct2/show/NCT04083599?term=Gen1042&draw=2&rank=1
-
Tirsdagens danske avisuddrag med Vestas, elbiler og kapitalfonde https://www.proinvestor.com/investornyt/922276/tirsdagens-danske-avisuddrag-med-vestas-elbiler-og-kapitalfonde
-
Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of Talquetamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma https://www.globenewswire.com/news-release/2023/01/03/2581869/0/en/Janssen-Submits-Marketing-Authorisation-Application-to-the-European-Medicines-Agency-Seeking-Approval-of-Talquetamab-for-the-Treatment-of-Patients-with-Relapsed-or-Refractory-Multi.html
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind